AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
Go back to AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions| (NASDAQ: ABCL) | Delayed: 12.70 +0.05 (0.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.65 | 52 Week High | $ | |||
| Open | $12.74 | 52 Week Low | $ | |||
| Day High | $12.93 | P/E | N/A | |||
| Day Low | $12.29 | EPS | $ | |||
| Volume | 3,382,858 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 526.19 +3.81 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $522.38 | 52 Week High | $134.71 | |||
| Open | $522.55 | 52 Week Low | $73.31 | |||
| Day High | $527.69 | P/E | N/A | |||
| Day Low | $518.92 | EPS | $-1.98 | |||
| Volume | 756,206 | |||||
